Kumquat Biosciences
Lynn Yang, focusing on healthcare investment. Prior to joining Sequoia Capital China in May,2015, Lynn worked at healthcare team of Legend Capital. Lynn accomplished investment deals in different area of healthcare industry such as Burning Rock, Cstone(2616.HK), JW Therapeutics, Grail, Hongkong Asia Medical, Qihan Bio (eGenesis counterpart in China), Hifibio etc. Before setting her foot in venture capital, Lynn worked as business development manager in Johnson & Johnson and product manager at GE Healthcare. Mrs. Yang holds a MBA from Duke University and Master of Clinical Science from Huazhong Technology University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Kumquat Biosciences
Kumquat Biosciences’ vision is to develop innovative therapies to bring about sustainable and life-changing benefits to cancer patients. They are committed to translating breakthrough science to innovative medicines by combining internal expertise in drug discovery and development, with external collaboration with academics.